It is medically supervised, biologically rational, supports hydration, requires no downtime and integrates naturally with the wider doctor-led wellness ecosystem vitamin therapy, NAD+ infusions, regenerative skin care that has matured in Dubai over the last few years
The simple answer
Mechanism of action: Both drugs fall into the class of medications known as GLP-1 receptor agonists that enhance insulin secretion, suppress glucagon release, and slow gastric emptying to help control blood sugar levels
Withdrawal symptoms can also occur when individuals stop taking GLP-1 medications: Reduced side effects: While semaglutide or tirzepatide can lead to side effects like acid reflux, nausea, constipation and abdominal pain, stopping the medication can reduce these side effects
Potential Adverse Effects The FDA flagged concerns about: Immunogenicity and antibody formation with repeated dosing Peptide-related impurities from compounding pharmacy manufacturing Unknown effects on cardiovascular, hepatic, and renal function with chronic use Theoretical acceleration of undetected tumor growth Current Research Gaps The literature reveals critical knowledge deficits preventing definitive cancer risk conclusions: Long-term human safety: No prospective study has followed BPC-157 users for months or years to document cancer incidence or tumor progression